C4 Therapeutics, Inc.
CCCCNasdaqCIK 1662579HealthcareFiscal year ends Dec 31
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2511:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063497 |
| 2026-08-1111:29 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055494 |
| 2026-08-1111:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055490 |
| 2026-06-2420:22 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-045194 |
| 2026-06-1111:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-042365 |
| 2026-05-1520:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-035542 |
| 2026-05-1211:07 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-033865 |
| 2026-05-1211:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-033861 |
| 2026-04-2911:00 ET | DEF 14A | Proxy statementPeriod 2026-04-29 | 0001628280-26-028104 |
| 2026-04-1011:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-26-024583 |
| 2026-04-0911:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-024336 |
| 2026-02-2612:49 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012000 |
| 2026-02-2612:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-011971 |
| 2026-01-1412:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-002010 |
| 2025-11-0612:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-049854 |
| 2025-11-0612:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049850 |
| 2025-10-1621:29 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-241591 |
| 2025-10-1610:30 ET | 8-K | 8.01 Other events | 0001628280-25-045157 |
| 2025-10-0111:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-043290 |
| 2025-09-2210:41 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-042245 |
| 2025-08-0711:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038587 |
| 2025-08-0711:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-038576 |
| 2025-06-1820:50 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-032155 |
| 2025-05-0711:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022866 |
| 2025-05-0711:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-022864 |
| 2025-04-2911:01 ET | DEF 14A | Proxy statementPeriod 2025-04-29 | 0001628280-25-020466 |
| 2025-04-1412:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-017612 |
| 2025-02-2712:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008433 |
| 2025-02-2712:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008429 |
| 2025-01-1412:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001628280-25-001433 |
| 2024-12-0914:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-050349 |
| 2024-11-2012:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-048593 |
| 2024-10-3111:12 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-044411 |
| 2024-10-3111:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044409 |
| 2024-10-1621:53 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-042879 |
| 2024-10-1520:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-042833 |
| 2024-10-1120:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-042728 |
| 2024-09-0311:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-039023 |
| 2024-08-0111:27 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-033882 |
| 2024-08-0111:11 ET | 8-K | 2.02 Results of operations | 0001628280-24-033874 |
| 2024-06-2120:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-029301 |
| 2024-06-1011:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-027399 |
| 2024-05-0811:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021368 |
| 2024-05-0811:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021367 |
| 2024-04-2912:03 ET | DEF 14A | Proxy statementPeriod 2024-04-29 | 0001628280-24-018785 |
| 2024-03-0821:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-009967 |
| 2024-03-0412:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-008339 |
| 2024-02-2212:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-006144 |
| 2024-02-2212:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006142 |
| 2024-01-1112:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-001085 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.